Carcinogenesis, Teratogenesis & Mutagenesis ›› 2017, Vol. 29 ›› Issue (5): 397-401.doi: 10.3969/j.issn.1004-616x.2017.05.016
Previous Articles Next Articles
Received:2017-05-11
Revised:2017-07-16
Online:2017-09-30
Published:2017-09-30
CLC Number:
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
| [1] MAGUER-SATTA V,BESANÇON R,BACHELARD-CASCALES E. Concise review:neutral endopeptidase (CD10):a multifaceted environment actor in stem cells,physiological mechanisms,and cancer[J]. Stem Cells,2011,29(3):389-396. [2] IWAYA K,OGAWA H,IZUMI M,et al. Stromal expression of CD10 in invasive breast carcinoma:a new predictor of clinical outcome[J]. Virchows Arch,2002,440(6):589-593. [3] 刘芸,廖晓龙. CD10分子的研究进展及临床应用[J]. 国际免疫学杂志,2014,37(5):363-366. [4] KIM J H,HWANG S E,YU H C,et al. Distribution of CD10-positive epithelial and mesenchymal cells in human mid-term fetuses:a comparison with CD34 expression[J]. Anat Cell Biol,2014,47(1):28-39. [5] KELLER P J,ARENDT L M,SKIBINSKI A,et al. Defining the cellular precursors to human breast cancer[J]. PNAS,2012,109(8):2772-2777. [6] GREAVES M F,HARIRI G,NEWMAN R A,et al. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts[J]. Blood,1983,61(4):628-639. [7] OGAWA H,IWAYA K,IZUMI M,et al. Expression of CD10 by stromal cells during colorectal tumor development[J]. Hum Pathol, 2002,33(8):806-811. [8] YAO T,TAKATA M,TUSTSUMI S,et al. Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis[J]. Pathology,2002,34(6):556-560. [9] FUJIMOTO Y,NAKANISHI Y,SEKINE S,et al. CD10 expression in colorectal carcinoma correlates with liver metastasis[J]. Dis Colon Rectum,2005,48(10):1883-1889. [10] SASAKI T,KUNIYASU H,LUO Y,et al. Serum CD10 is associated with liver metastasis in colorectal cancer[J]. J Surg Res,2014, 192(2):390-394. [11] FUJITA S,TANIGUCHI H,YAO T,et al. Multi-institutional study of risk factors of liver metastasis from colorectal cancer:correlation with CD10 expression[J]. Int J Colorectal Dis,2010,25(6):681-686. [12] FUJITA S,YAMAMOTO S,AKASU T,et al. Quantification of CD10 mRNA in colorectal cancer and relationship between mRNA expression and liver metastasis[J]. Anticancer Res,2007,27(5A):3307-3311. [13] LUO Y,FUJⅡ K,OHMORI H,et al. Antisense phosphorothioate oligodeoxynucleic acid for CD10 suppresses liver metastasis of colorectal cancer[J]. Pathobiology,2009,76(5):267-273. [14] OHJI Y,YAO T,EGUCHI T,et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression:multivariate analysis of clinicopathological and immunohistochemical factors[J]. Oncol Rep, 2007,17(3):525. [15] KHANH D T,MEKATA E,MUKAISHO K,et al. Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage Ⅱ colorectal cancer[J]. Int J Clin Oncol,2012,17:240-249. [16] KHANH D T,MEKATA E,MUKAISHO K,et al. Prognostic role of CD10+ myeloid cells in association with tumor budding at the invasion front of colorectal cancer[J]. Cancer Sci,2011,102(9):1724-1733. [17] JANG T J,PARK J B,LEE J I. The expression of CD10 and CD15 is progressively increased during colorectal cancer development[J]. Korean J Pathol,2013,47(4):340-347. [18] HIRANO K,NIMURA S,MIZOGUCHI M,et al. Early colorectal carcinomas:CD10 expression,mucin phenotype and submucosal invasion[J]. Pathol Int,2012,62(9):600-611. [19] DEL RIO P,CRAFA P,PAPADIA C,et al. Is CD10 a reliable marker of invasive colorectal cancer?[J]. Ann Ital Chir,2011,82(4):279-282. [20] DEL RIO P,CRAFA P,PAPADIA C,et al. Evaluation of CD10 positivity in colorectal polyps in neoplastic transformation[J]. Ann Ital Chir,2010,81(2):121-127. [21] NISHIDA T,EGASHIRA Y,AKUTAGAWA H,et al. Predictors of lymph node metastasis in T1 colorectal carcinoma:an immunophenotypic analysis of 265 patients[J]. Dis Colon & Rectum,2014,57(8):905-915. [22] KUNIYASU H,LUO Y,FUJⅡ K,E T al. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoral effect of methionine-enkephalin in the liver[J]. Gut,2010,59(3):348-356. [23] BERNESCU I,REICHSTEIN A C,LUCHTEFELD M,et al. Does CD10 expression predict lymph node metastasis in colorectal cancer?[J]. Dis Colon Rectum,2016,59(1):22-27. [24] JANA S H,JHA B M,PATEL C,et al. CD10-a new prognostic stromal marker in breast carcinoma,its utility,limitations and role in breast cancer pathogenesis[J]. Indian J Pathol Microbiol,2014, 57(4):530. [25] THOMAS S,BABU R J,AGARWAL K,et al. Effect of neoadjuvant chemotherapy on stromal CD10 antigens in breast cancer-A preliminary study[J]. Indian J Cancer,2013,50(1):46. [26] TAGHIZADEH-KERMANI A,JAFARIAN A H,ASHABYAMIN R,et al. The stromal overexpression of CD10 in invasive breast cancer and its association with clincophathologic factors[J]. Iran J Cancer Prev,2014,7(1):17. [27] KIM H S,KIM G Y,KIM Y W,et al. Stromal CD10 expression and relationship to the E-cadherin/β-catenin complex in breast carcinoma[J]. Histopathology,2010,56(6):708-719. [28] WITKIEWICZ A K,FREYDIN B,CHERVONEVA I,et al. Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence[J]. Cancer Biol Ther,2010,10(4):391-396. [29] FLEISCHMANN A,ROCHA C,SAXER-SEKULIC N,et al. High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death[J]. Virchows Arch, 2011,458(6):741-748. [30] FLEISCHMANN A,SCHLOMM T,HULAND H,et al. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients[J]. Clin Cancer Res,2008,14(23):7838-7842. [31] HO M E,QUEK S I,TRUE L D,et al. Prostate cancer cell phenotypes based on AGR2 and CD10 expression[J]. Mod Pathol, 2013,26(6):849-859. [32] OMRAN O M. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma[J]. J Environ Pathol Toxicol Oncol, 2012,31(3). [33] ABDOU A G. CD10 expression in tumor and stromal cells of bladder carcinoma:an association with bilharziasis[J]. Apmis,2007,115(11):1206-1218. [34] BAHADIR B,BEHZATOGLU K,BEKTAS S,et al. CD10 expression in urothelial carcinoma of the bladder[J]. Diagn Pathol,2009,4(1):1. [35] ATIQUE M,ABBASI M S,JAMAL S,et al. CD10 Expression intensity in various grades and stages of urothelial carcinoma of urinary bladder[J]. J Coll Physicians Surg Pak,2014,24(5):351-355. [36] SEILER R,VON GUNTEN M,THALMANN G N,et al. High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients[J]. Hum Pathol,2012,43(2):269-275. [37] BIRCAN S,CANDIR O,KAPUCUOGLU N,et al. CD10 expression in urothelial bladder carcinomas:a pilot study[J]. Urol Int,2006, 77(2):107-113. [38] 奉松青,郭凯,郑少波,等. 膀胱移行细胞癌CD10的表达及其临床意义[J]. 实用医学杂志,2013,29(7):1117-1119. [39] HUANG W B,ZHOU X J,CHEN J Y,et al. CD10-positive stromal cells in gastric carcinoma:correlation with invasion and metastasis[J]. Jpn J Clin Oncol,2005,35(5):245-250. [40] KADOTA K,BUITRAGO D,LEE M C,et al. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma[J]. Lung Cancer,2015,89(3):329-336. [41] LEE K W,SUNG C O,KIM J H,et al. CD10 expression is enhanced by twist and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo[J]. Int J Cancer,2015,136(2):310-321. [42] IKENAGA N,OHUCHIDA K,MIZUMOTO K,et al. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer[J]. Gastroenterology,2010,139(3):1041-1051. [43] 周春辉,黄世章. 胰腺癌细胞中CD10 mRNA的表达与肿瘤恶性程度及转移的关系[J]. 广东医学,2011,32(12):1555-1557. [44] BRAHAM H,TRIMECHE M,ZIADI S,et al. CD10 expression by fusiform stromal cells in nasopharyngeal carcinoma correlates with tumor progression[J]. Virchows Arch,2006,449(2):220-224. [45] FUKUSUMI T,ISHⅡ H,KONNO M,et al. CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma[J]. Br J Cancer,2014,111(3):506-514. [46] KADOTA K,VILLENA-VARGAS J,NITADORI J,et al. Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma[J]. Ann Surg Oncol, 2015,22(9):3136-3143. |
| [1] | LIU Ning, LIANG Lanlan, LI Shufang, SHEN Xiangchun, LIANG Bing. Anti-tumor effects of oxymatrine on mouse sarcoma and live cancers in vivo and in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 426-429,434. |
| [2] | . [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(2): 149-154. |
| [3] | . [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(2): 162-165. |
| [4] | DING Wenping, LU Yuanyuan, TONG Wenxia, ZHOU Aibin, KONG Xiang, CHEN Yihong. Induction of apoptosis in HepG2 hepatocellular carcinoma cells by chloroquine via the P38MAPK pathway [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 430-434. |
| [5] | LIU Dan, JIAO Liangbo, ZHANG Wen, WANG Xinyi, CHEN Tao, HU Wei. Effect of Chinese herbal compound QHF on human Huh7 hepatoma cell proliferation and invasion, and expression of surface markers of cancer stem cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(3): 171-175. |
| [6] | HU Qiong, YOU Shuping, LIU Tao, WANG Bo, LIU Xin, JIANG Yuandong. An investigation on the anti-liver cancer effect of cistanche [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(3): 194-199. |
| [7] | ZUO Ran, REN Xiaohu, WU Desheng, LI Ping, WU Wen, XIE Ni, YUAN Jianhui, RANG Weiqing. Bioinformation analysis of data regarding breast cancer prognosis in European and American populations [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(2): 103-108. |
| [8] | LIU Hao, ZHAO Yingying, JIN Ping, XU Gaixia, GUO Yuran, ZHANG Ke, WANG Xiaomei, ZHANG Lei. Histone deacetylase inhibitor restrained proliferation of human cervical cancer cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(5): 335-339. |
| [9] | YANG Meiling, LI Xin, HUANG Junming, ZHANG Zihong, YI Zimei, GU Meiying, HUANG Jiankang, HE Yun. Enhancement of anti-tumor effect of cisplatin by chrysin in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2017, 29(1): 37-41,59. |
| [10] | QI Xuesong, LI Ning, WANG Chunyan, TONG Peng, GOU Qiao, ZHENG Hui. Effect of vinorelbine tartrate lipid microsphere injection on growth of human breast cancer cells in nude mice [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2016, 28(2): 103-106. |
| [11] | WU Huatao, SHEN Jiaxin, LIU Jing. Overexpression of Notch3 enhance the efficacy of cisplatin to MDA-MB-231 [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2016, 28(2): 111-114,120. |
| [12] | SI Ya-ru1;LI Shan-shan1;JIANG Xia2;WANG Si-ming3;LI Xue-hui1;ZHENG Yan1;SHI Qing-wen3;DONG Mei2;ZHANG Hong-zhen1. Study of the anti-proliferative activity and mechanism of three sesquiterpene compounds on gynecologic tumor cell lines [J]. , 2010, 22(1): 28-0031. |
| [13] | LAI Yan-dong;LU Jia-chun;LI Xiu-ying;BIN Xiao-nong;WU Jian-jun. Study of RNA Interference Induced Expression Silence of DNA Repaired Gene hMGMT [J]. , 2006, 18(1): 9-011. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
